BIFIDO Co., Ltd. (KOSDAQ:238200)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,740.00
+15.00 (0.55%)
At close: May 29, 2026
Market Cap22.05B -17.5%
Revenue (ttm)17.23B +21.9%
Net Income-1.89B
EPS-229.88
Shares Out 8.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume27,539
Open2,700.00
Previous Close2,725.00
Day's Range2,700.00 - 2,915.00
52-Week Range2,460.00 - 4,390.00
Beta0.85
Analystsn/a
Price Targetn/a
Earnings DateMay 28, 2026

About BIFIDO

BIFIDO Co., Ltd. produces probiotics-based products in South Korea and internationally. It offers bifidobacterium strain products, such as BGN4 for immune modulating; BORI used to treat rotavirus infection in infants; and AD011 for general intestinal health problems. The company was founded in 1999 and is headquartered in Hongcheon-eup, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1999
Employees 83
Stock Exchange KOSDAQ
Ticker Symbol 238200
Full Company Profile

Financial Performance

In 2025, BIFIDO's revenue was 19.68 billion, an increase of 59.34% compared to the previous year's 12.35 billion. Losses were -192.74 million, -96.43% less than in 2024.

Financial Statements